|
Volumn 37, Issue 6, 2005, Pages 2840-2842
|
Immunosuppressive drugs after simultaneous pancreas-kidney transplantation
a,b,c a a a,c a,c a,c a,c a,c c c c c c c c c c c c c more..
c
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CORTICOSTEROID;
CYCLOSPORIN;
IMMUNOMODULATING AGENT;
IMMUNOSUPPRESSIVE AGENT;
MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;
RECOMBINANT ANTIBODY;
TACROLIMUS;
THYMO S;
THYMOCYTE ANTIBODY;
UNCLASSIFIED DRUG;
CLINICAL TRIAL;
COMPARATIVE STUDY;
CONFERENCE PAPER;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CORTICOSTEROID THERAPY;
DISEASE ASSOCIATION;
DRUG DOSE REDUCTION;
DRUG EFFICACY;
DRUG INDICATION;
DRUG SAFETY;
DRUG TOLERABILITY;
DRUG WITHDRAWAL;
GRAFT FAILURE;
GRAFT REJECTION;
HUMAN;
IMMUNOSUPPRESSIVE TREATMENT;
INFECTION;
KIDNEY GRAFT REJECTION;
KIDNEY TRANSPLANTATION;
LEUKOCYTE COUNT;
MAJOR CLINICAL STUDY;
MALIGNANT NEOPLASTIC DISEASE;
MICROEMULSION;
MULTICENTER STUDY;
PANCREAS TRANSPLANTATION;
POSTOPERATIVE CARE;
PRIORITY JOURNAL;
RANDOMIZATION;
RANDOMIZED CONTROLLED TRIAL;
SHORT COURSE THERAPY;
SIDE EFFECT;
SIMULTANEOUS PANCREAS KIDNEY TRANSPLANTATION;
THROMBOCYTE COUNT;
THROMBOSIS;
|
EID: 25144457148
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: 10.1016/j.transproceed.2005.05.022 Document Type: Article |
Times cited : (10)
|
References (2)
|